Jennifer Simpson
Chief Executive Officer at PANBELA THERAPEUTICS, INC.
Net worth: 572 $ as of 2024-03-30
Profile
Jennifer K.
Simpson is currently the President, Chief Executive Officer & Director at Panbela Therapeutics, Inc. She is also the Chairman at LadRx Corp.
and the Lead Independent Director at Eagle Pharmaceuticals, Inc. Previously, she served as the President, Chief Executive Officer & Director at Delcath Systems, Inc. from 2015 to 2020.
She was also the Product Director-Oncology Therapeutics Marketing at Janssen Biotech, Inc. from 2006 to 2008 and the VP-Global Marketing, Oncology Brand at ImClone LLC from 2011 to 2012.
Dr. Simpson holds a graduate degree from Rochester Christian University, a doctorate degree from the University of Pittsburgh, and an undergraduate degree from the State University of New York at Buffalo.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LADRX CORPORATION
0.05% | 2024-01-14 | 250 ( 0.05% ) | 568 $ | 2024-03-30 |
PANBELA THERAPEUTICS INC
0.00% | 2024-03-26 | 7 ( 0.00% ) | 5 $ | 2024-03-30 |
| 2023-03-30 | 0 ( -.--% ) | - $ | 2024-03-30 |
Jennifer Simpson active positions
| Companies | Position | Start |
|---|---|---|
| EAGLE PHARMACEUTICALS, INC. | Director/Board Member | 2019-08-27 |
| PANBELA THERAPEUTICS, INC. | Chief Executive Officer | 2020-07-15 |
| LADRX CORPORATION | Chairman | 2022-07-26 |
Former positions of Jennifer Simpson
| Companies | Position | End |
|---|---|---|
| DELCATH SYSTEMS, INC. | Chief Executive Officer | 2020-05-31 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 2010-12-31 |
Janssen Biotech, Inc.
 Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Janssen Biotech, Inc. engages in the development and marketing of prescription drugs. The company is headquartered in Horsham, PA. | Sales & Marketing | 2007-12-31 |
Training of Jennifer Simpson
| Rochester Christian University | Graduate Degree |
| University of Pittsburgh | Doctorate Degree |
| State University of New York at Buffalo | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| LADRX CORPORATION | Health Technology |
| DELCATH SYSTEMS, INC. | Health Technology |
| EAGLE PHARMACEUTICALS, INC. | Health Technology |
| PANBELA THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Janssen Biotech, Inc.
Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Janssen Biotech, Inc. engages in the development and marketing of prescription drugs. The company is headquartered in Horsham, PA. | Health Technology |
- Stock Market
- Insiders
- Jennifer Simpson
